Symposia

 

Breakfast Symposia

NHIA symposia programs add tremendous value to your annual conference learning experience—offering clinically relevant content from subject-matter experts!

Tuesday, April 24 • 7:00 – 9:00 AM

Part 1: Breakfast Symposium
Understanding an Under-Recognized Complication: CVAD-Associated Skin Impairment

Evidence supporting the assessment and management of central venous access device (CVAD) sites with skin impairment is limited and thus challenging for clinicians. An international advisory panel has published an algorithm to guide the clinician on assessment, identification and prevention of skin injury, contact dermatitis, non-infectious exudate, and exit site infections. This is your opportunity to learn how to maintain your patient’s skin health at CVAD sites.

Faculty: Daphne Broadhurst, RN, BScN, CVAA. Clinical Specialist and Innovations Lead, Medical Pharmacies Group Limited

Support for this activity has been received from 3M Health Care Academy

Part 2: Product Tutorial
Effective Management of Skin Complications in Home Infusion

Minimizing CVAD complications in home-based patients requires knowledgeable clinicians, educated patients and caregivers, as well as the right products. Join 3M’s team of experts to walk through a series of case-based scenarios, including demonstration and hands-on practice in the prevention of a wide range of CVAD complications.

 


Tuesday, April 24 • 7:00 – 9:00 AM

Immune-Mediated Neuromuscular Disorders: Understanding the Evidence and Indications of Immunoglobulin Therapy (1.5 CE)

In recent years, the growth of indications for immunoglobulin therapy has grown considerably, with clear evidence of the effectiveness for the treatment of Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy (Lunemann, Quast, & Dalakas, 2016). The use of Ig therapy in the field of neuromuscular disorders is expanding. Clinical trials investigating the feasibility and efficacy of SCIg in neurological disorders are underway in the United States. These changing dynamics might allow for patients to have a more active role in their treatment options requiring home infusion clinicians to be well versed in the evidence supporting SCIg indications. Gaining in-depth understanding of the treatment rationale, route, dosing, infusion protocols, appropriate administration and assessment, and understanding of potential adverse reactions is critical to healthcare professionals managing patients in the home environment. This program aims to bring a clear understanding to home infusion clinicians of the expanding indications for Ig in the treatment of immune-mediated neuromuscular disorders as well as the emerging evidence regarding SCIg in this patient population.

Faculty: Mazen M Dimachkie, M.D.

Supported by an educational grant from CSL Behring

 


Wednesday, April 25 • 7:00 – 9:00 AM

Solutions for Surviving Shortages: How To Care for Nutrition Patients During an IV Solutions Crisis

In the wake of Hurricane Maria, which destroyed major solution supply production facilities in Puerto Rico, organizations were required to take immediate action to ensure the safety of this tenuous patient population. Organizations such as the FDA, A.S.P.E.N., and NHIA worked diligently to provide parenteral nutrition (PN) providers with up-to-date information on drug shortages, clinical management strategies, and potential alternatives to appropriate patient segments. As the crisis created by Hurricane Maria begins to lift, it is important to learn from previous struggles and develop a long-term strategy for dealing with PN drug shortages. This program will provide an overview of the present and historical perspective of PN drug shortages, outline the need for future action to prevent shortages, and provide comprehensive conservation and patient prioritization strategies. In addition, the program will strive to ensure home infusion providers understand the most appropriate methods to manage the reimbursement challenges that result from managing this patient population during a fluid crisis.

Faculty: Carol J Rollins, MS, RD, PharmD, CNSD, BCNSP, Coordinator, Nutrition Support Team, University of Arizona Medicare Center; Rodney Wright President, TANYR, Healthcare

Supported by an educational grant from Fresenius Kabi USA

 


Thursday, April 26 • 7:00 – 9:00 AM

Understanding the Role of Home Infusion as Part of a Multidisciplinary Approach to Care for the Patient with Amyotrophic Lateral Sclerosis

Today, home infusion clinicians are involved in the management of a wide range of patients, including those diagnosed with Amyotrophic Lateral Sclerosis (ALS). This program will provide multidisciplinary team members the core knowledge and skills needed to effectively manage their ALS patients throughout the disease process. An overview of current treatment regimens, complimentary therapies, and methods to identify and treat symptoms associated with disease progression will be provided. Pharmacists, nurses, and dietitians involved in caring for patients with ALS will benefit from discussing appropriate treatment and interventions to prevent complications and the development of co-morbidities. The development of a clear strategy for reimbursement will be reviewed.

Faculty: Lora L Clawson, MSN, CRNP, Director of ALS Clinical Services, Johns Hopkins

Supported by an educational grant from MT Pharma

Top